Literature DB >> 12819111

Different strains of Toxoplasma gondii induce different cytokine responses in CBA/Ca mice.

Fausto G Araujo1, Teri Slifer.   

Abstract

To investigate the role that cytokines may have in the development of toxoplasmic encephalitis (TE), the levels of gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), interleukin-12 (IL-12 ]p40[), IL-10, IL-6, IL-4, and IL-2 in serum were examined in CBA/Ca mice infected with a type II strain (ME49 or FORT) of Toxoplasma gondii. These strains caused severe (ME49) or mild (FORT) TE in CBA/Ca mice. From weeks 1 to 8 of infection, the levels of IL-6, IL-10, IL-12, IFN-gamma, and TNF-alpha in serum were significantly higher in the ME49-infected mice than in the FORT-infected mice, suggesting a role for these cytokines in the severity of TE in CBA/Ca mice. Since the ME49 and FORT strains are of the same type, our results suggest a role for the parasite in the development of severe TE through the increased production of proinflammatory cytokines and indicate that not all type II strains cause TE.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819111      PMCID: PMC162004          DOI: 10.1128/IAI.71.7.4171-4174.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines.

Authors:  D G Mordue; F Monroy; M La Regina; C A Dinarello; L D Sibley
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

2.  Depletion of L3T4+ (CD4+) T lymphocytes prevents development of resistance to Toxoplasma gondii in mice.

Authors:  F G Araujo
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

3.  Recent advances in the search for new drugs for treatment of toxoplasmosis.

Authors:  F G Araujo; J S Remington
Journal:  Int J Antimicrob Agents       Date:  1992       Impact factor: 5.283

4.  Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis.

Authors:  D K Howe; S Honoré; F Derouin; L D Sibley
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

5.  Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon.

Authors:  Y Suzuki; F K Conley; J S Remington
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

6.  The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection.

Authors:  F G Araujo; A A Khan; T L Slifer; A Bryskier; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

7.  Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease.

Authors:  D K Howe; L D Sibley
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

8.  Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation.

Authors:  R T Gazzinelli; I Eltoum; T A Wynn; A Sher
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

9.  Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice.

Authors:  F G Araujo; Y Suzuki; J S Remington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

10.  Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii.

Authors:  O Liesenfeld; J Kosek; J S Remington; Y Suzuki
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

View more
  11 in total

1.  Strains of Toxoplasma gondii used for tachyzoite antigens to stimulate spleen cells of infected mice in vitro affect cytokine responses of the cells in the culture.

Authors:  Laurel Rodgers; Xisheng Wang; Xiangshu Wen; Bradley Dunford; Renee Miller; Yasuhiro Suzuki
Journal:  Parasitol Res       Date:  2005-07-07       Impact factor: 2.289

Review 2.  Effects of Toxoplasma gondii infection on the brain.

Authors:  Vern B Carruthers; Yasuhiro Suzuki
Journal:  Schizophr Bull       Date:  2007-02-23       Impact factor: 9.306

3.  Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?

Authors:  Joanne P Webster; Maya Kaushik; Greg C Bristow; Glenn A McConkey
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

4.  Analysis of Toxoplasma gondii surface antigen 2 gene (SAG2). Relevance of genotype I in clinical toxoplasmosis.

Authors:  Valeria Sabaj; Mario Galindo; Daniela Silva; Lea Sandoval; Juan C Rodríguez
Journal:  Mol Biol Rep       Date:  2009-10-20       Impact factor: 2.316

5.  The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice.

Authors:  Christian Jost; Ingrid Reiter-Owona; Oliver Liesenfeld
Journal:  Parasitol Res       Date:  2007-09-12       Impact factor: 2.289

6.  Atovaquone ameliorate gastrointestinal toxoplasmosis complications in a pregnancy model.

Authors:  Helieh S Oz; Thomas Tobin
Journal:  Med Sci Monit       Date:  2012-09

7.  Behavioral and Neuropathological Changes After Toxoplasma gondii Ocular Conjunctival Infection in BALB/c Mice.

Authors:  Gabrielly Lisboa da Silva Soares; Ellen Rose Leandro Ponce de Leão; Sinara Franco Freitas; Raissa Maria Carvalho Alves; Naiana de Paula Tavares; Maria Vitória Nascimento Costa; Gabriel Castro de Menezes; Jhonnathan Henrique Palheta de Oliveira; Luma Cristina Ferreira Guerreiro; Alexa Camila Lopes de Assis; Sanderson Corrêa Araújo; Felipe Tuji de Castro Franco; Ana Karyssa Mendes Anaissi; Ediclei Lima do Carmo; Rafaela Dos Anjos Pinheiro Bogoevich Morais; Samia Demachki; José Antonio Picanço Diniz; Heloisa Marceliano Nunes; Daniel C Anthony; Daniel Guerreiro Diniz; Cristovam Wanderley Picanço Diniz
Journal:  Front Cell Infect Microbiol       Date:  2022-03-09       Impact factor: 5.293

8.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

9.  Aggravation of symptom severity in adult attention-deficit/hyperactivity disorder by latent Toxoplasma gondii infection: a case-control study.

Authors:  Alexandra P Lam; Dominik de Sordi; Helge H O Müller; Martin C Lam; Angelika Carl; Klaus P Kohse; Alexandra Philipsen
Journal:  Sci Rep       Date:  2020-09-01       Impact factor: 4.379

10.  Transcriptomics analysis of Toxoplasma gondii-infected mouse macrophages reveals coding and noncoding signatures in the presence and absence of MyD88.

Authors:  Kayla L Menard; Lijing Bu; Eric Y Denkers
Journal:  BMC Genomics       Date:  2021-02-23       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.